Utility of first positron emission tomography-computed tomography scan as a prognostic tool following treatment of sinonasal and skull base malignancies

Head Neck. 2019 Mar;41(3):701-706. doi: 10.1002/hed.25416. Epub 2018 Dec 6.

Abstract

Background: The prognostic value of the first posttreatment whole body integrated positron emission tomography-computed tomography (PET/CT) scanning in patients with sinonasal/skull base malignancies is undetermined.

Methods: We retrospectively reviewed the data of all patients that underwent surgery for sinonasal/skull base malignancies in 2000-2015. The results of the pretreatment and posttreatment PET/CT findings and the clinical course were retrieved.

Results: Thirty-eight patients (average age 60.6 years, 20 males) were included. Sensitivity and specificity, positive predictive value, and negative predictive value of the first PET/CT scan for predicting persistent/recurrent disease were 85.7%, 87.5%, 80%, and 91.3%, respectively. Overall 5-year survival was significantly lower in the first posttreatment PET/CT-positive group (35%) compared to the PET/CT-negative group (93%) (P = .0008).

Conclusion: Posttreatment PET/CT findings are highly prognostic in patients with sinonasal/skull base malignancies. Negative findings on the first posttreatment PET/CT scan predict a significantly better overall survival.

Keywords: PET/CT; prognosis; sinonasal malignancy; skull base; survival.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Male
  • Middle Aged
  • Paranasal Sinus Neoplasms / diagnostic imaging*
  • Paranasal Sinus Neoplasms / mortality
  • Paranasal Sinus Neoplasms / surgery*
  • Positron Emission Tomography Computed Tomography*
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Skull Base Neoplasms / diagnostic imaging*
  • Skull Base Neoplasms / mortality
  • Skull Base Neoplasms / surgery*
  • Survival Rate
  • Treatment Outcome
  • Whole Body Imaging
  • Young Adult

Substances

  • Fluorodeoxyglucose F18